Skin Cancer

Nanotechnology: An opportunity to advance skin cancer treatment
July 01, 2020

In cancer immunotherapy, nanoparticles can be directed to different cells and tissues related to the immune response. This technology is currently being investigated to enhance drug delivery in skin cancer therapy with the hope of promoting more robust antitumor effects and improved clinical outcomes.

Gene expression profiling for skin cancer brings promise, pitfalls
June 30, 2020

Gene expression profiling (GEP) has the potential to improve melanoma prognostication, says an expert, but shortcomings remain, one expert says.

Pembrolizumab approved by FDA for cSCC
June 25, 2020

The U.S. Food and Drug Administration has approved pembrolizumab for cutaneous squamous cell carcinoma whose disease has shown to not be curable by radiation or surgery.